Pfizer
Kim Zerrenner has a diverse work experience spanning from 1992 to the present. Kim has worked for various companies in different roles within the field of Human Resources. Kim's most recent experience includes serving as the SVP of Human Resources for Pfizer's Research & Development and Business Innovation division, a role they have held since June 2021. Prior to that, they served as the SVP of Human Resources for Pfizer Worldwide Research & Development, Global Product Development & Digital from 2018 to 2021. Before joining Pfizer, Kim held various Vice President roles in Human Resources at different times for Pfizer, Fidelity Investments, and Principal Financial Group. Kim also gained experience in HR at Reebok and Eli Lilly and Company earlier in their career. Additionally, they worked for GE as an HRMP from 1992 to 1994.
Kim Zerrenner obtained a Bachelor of Arts degree in English / Education, Org Behavior / Comm from Michigan State University in 1990. Kim then pursued a Master of Labor and Industrial Relations (MLIR) degree in Business / Labor Relations from the same university, completing it in 1992.
This person is not in any offices
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.